Predictors of mortality in rheumatoid arthritis-associated lung disease: A retrospective study on ten years

被引:19
作者
Ekici, Mustafa [1 ]
Baytar, Yusuf [2 ]
Kardas, Riza Can [1 ]
Sari, Alper [3 ]
Akdogan, Ali [3 ]
Durhan, Gamze [2 ]
Ariyurek, Macit [2 ]
Kalyoncu, Umut [3 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Internal Med, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Radiol, Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey
关键词
Rheumatoid arthritis; Lung involvement; Mortality; INVOLVEMENT; PATTERN; COHORT;
D O I
10.1016/j.jbspin.2021.105133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Rheumatoid arthritis (RA)-associated lung involvement is a cause of mortality. This study aimed to evaluate mortality rate and mortality-associated factors in RA patients with high-resolution computed tomography (HRCT)-proven lung involvement. Methods: Patients followed-up for RA between 2010 and 2018 were evaluated regarding HRCT-proven lung involvement. The present study was designed as a single-centre, retrospective and descriptive study. The HRCT reports of patients were re-evaluated for three major patterns: UIP, nonspecific interstitial pneumonia (NSIP), and isolated airway disease (AD). Mortality rates and its associated factors (demographic characteristics, RA-related factors and lung-involvement-related factors) were determined. Results: The study included 156 patients (females, 68.3%) with radiologically confirmed RA-associated lung disease. The mean age was 55.5 (12.1) years at RA diagnosis and 62.7 (9.7) years at the diagnosis of lung involvement. The patterns of lung involvement on HRCT were UIP in 89 (57.0%) patients, NSIP in 51 (32.7%) patients, and isolated AD in 16 (10.3%) patients. The RA patients were followed-up for a mean of 10.2 (7.4) years and they were followed-up for a mean of 4.5 (3.7) years after interstitial lung disease (ILD) diagnosis. Overall, 40 (25.6%) patients died. The 5-year survival rate was 78%. Multivariate analysis revealed UIP pattern (log-rank test, P < 0.01), pleural effusion (log-rank test, P < 0.05), and a shorter time interval (<3 years) between the diagnoses of RA and RA-ILD (log-rank test, P < 0.01) to be independent predictors of mortality. Conclusions: In addition to the UIP, a known risk factor, pleural effusion and the short time between the diagnoses of RA and ILD were also found to be associated with mortality. (c) 2021 Socie acute accent te acute accent franc , aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:7
相关论文
共 15 条
[1]   Intra-thoracic rheumatoid arthritis: Imaging spectrum of typical findings and treatment related complications [J].
Chansakul, Thanissara ;
Dellaripa, Paul F. ;
Doyle, Tracy J. ;
Madan, Rachna .
EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (10) :1981-1991
[2]   The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment [J].
Duarte, Ana C. ;
Porter, Joanna C. ;
Leandro, Maria J. .
RHEUMATOLOGY, 2019, 58 (11) :2031-2038
[3]   Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease [J].
Enomoto, Yasunori ;
Nakamura, Yutaro ;
Colby, Thomas V. ;
Johkoh, Takeshi ;
Sumikawa, Hiromitsu ;
Nishimoto, Koji ;
Yoshimura, Katsuhiro ;
Matsushima, Sayomi ;
Oyama, Yoshiyuki ;
Hozumi, Hironao ;
Kono, Masato ;
Fujisawa, Tomoyuki ;
Enomoto, Noriyuki ;
Inui, Naoki ;
Iwashita, Toshihide ;
Suda, Takafumi .
PLOS ONE, 2017, 12 (06)
[4]   Nonspecific interstitial pneumonia [J].
Flaherty, Kevin R. ;
Martinez, Fernando J. .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (06) :652-658
[5]   A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality [J].
Hyldgaard, Charlotte ;
Hilberg, Ole ;
Pedersen, Alma Becic ;
Ulrichsen, Sinna Pilgaard ;
Lokke, Anders ;
Bendstrup, Elisabeth ;
Ellingsen, Torkell .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (10) :1700-1706
[6]   Methotrexate and rheumatoid arthritis associated interstitial, Lung disease [J].
Juge, Pierre-Antoine ;
Lee, Joyce S. ;
Lau, Jessica ;
Kawano-Dourado, Leticia ;
Serrano, Jorge Rojas ;
Sebastiani, Marco ;
Koduri, Gouri ;
Matteson, Eric ;
Bonfiglioli, Karina ;
Sawamura, Marcio ;
Kairalla, Ronaldo ;
Cavagna, Lorenzo ;
Cassione, Emanuele Bozzalla ;
Manfredi, Andreina ;
Mejia, Mayra ;
Rodriguez-Henriquez, Pedro ;
Gonzalez-Perez, Montserrat I. ;
Falfan-Valencia, Ramces ;
Buendia-Roldan, Ivette ;
Perez-Rubio, Gloria ;
Ebstein, Esther ;
Gazal, Steven ;
Borie, Raphael ;
Ottaviani, Sebastien ;
Kannengiesser, Caroline ;
Wallaert, Benoit ;
Uzunhan, Yurdagul ;
Nunes, Hilario ;
Valeyre, Dominique ;
Saidenberg-Kermanac, Nathalie ;
Boissier, Marie-Christophe ;
Wemeau-Stervinou, Lidwine ;
Flipo, Rene-Marc ;
Marchand-Adam, Sylvain ;
Richette, Pascal ;
Allanore, Yannick ;
Dromer, Claire ;
Truchetet, Marie-Elise ;
Richez, Christophe ;
Schaeverbeke, Thierry ;
Liote, Huguette ;
Thabut, Gabriel ;
Deane, Kevin D. ;
Solomon, Joshua J. ;
Doyle, Tracy ;
Ryu, Jay H. ;
Rosas, Ivan ;
Holers, V. Michael ;
Boileau, Catherine ;
Debray, Marie-Pierre .
EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
[7]   Histopathologic pattern and clinical features of rheumatoid arthritis associated interstitial lung disease [J].
Lee, HK ;
Kim, DS ;
Yoo, B ;
Seo, PB ;
Rho, JY ;
Colby, TV ;
Kitaichi, M .
CHEST, 2005, 127 (06) :2019-2027
[8]   HLA-DRB1 Alleles and Rheumatoid Arthritis-related Pulmonary Fibrosis [J].
Migita, Kiyoshi ;
Nakamura, Tadashi ;
Koga, Tomohiro ;
Eguchi, Katsumi .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) :205-208
[9]   Rheumatoid Arthritis (RA) associated interstitial lung disease (ILD) [J].
O'Dwyer, David N. ;
Armstrong, Michelle E. ;
Cooke, Gordon ;
Dodd, Jonathan D. ;
Veale, Douglas J. ;
Donnelly, Seamas C. .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (07) :597-603
[10]   Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review [J].
Roubille, Camille ;
Haraoui, Boulos .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 43 (05) :613-626